These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 15529346

  • 1. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus.
    Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, Sanz I.
    Arthritis Rheum; 2004 Nov; 50(11):3580-90. PubMed ID: 15529346
    [Abstract] [Full Text] [Related]

  • 2. Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus.
    Albert D, Dunham J, Khan S, Stansberry J, Kolasinski S, Tsai D, Pullman-Mooar S, Barnack F, Striebich C, Looney RJ, Prak ET, Kimberly R, Zhang Y, Eisenberg R.
    Ann Rheum Dis; 2008 Dec; 67(12):1724-31. PubMed ID: 18250115
    [Abstract] [Full Text] [Related]

  • 3. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy.
    Anolik JH, Barnard J, Owen T, Zheng B, Kemshetti S, Looney RJ, Sanz I.
    Arthritis Rheum; 2007 Sep; 56(9):3044-56. PubMed ID: 17763423
    [Abstract] [Full Text] [Related]

  • 4. B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab.
    Looney RJ, Anolik JH, Campbell D, Felgar RE, Young F, Arend LJ, Sloand JA, Rosenblatt J, Sanz I.
    Arthritis Rheum; 2004 Aug; 50(8):2580-9. PubMed ID: 15334472
    [Abstract] [Full Text] [Related]

  • 5. The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus.
    Anolik JH, Campbell D, Felgar RE, Young F, Sanz I, Rosenblatt J, Looney RJ.
    Arthritis Rheum; 2003 Feb; 48(2):455-9. PubMed ID: 12571855
    [Abstract] [Full Text] [Related]

  • 6. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response.
    Cambridge G, Isenberg DA, Edwards JC, Leandro MJ, Migone TS, Teodorescu M, Stohl W.
    Ann Rheum Dis; 2008 Jul; 67(7):1011-6. PubMed ID: 17962238
    [Abstract] [Full Text] [Related]

  • 7. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis.
    Leandro MJ, Cambridge G, Ehrenstein MR, Edwards JC.
    Arthritis Rheum; 2006 Feb; 54(2):613-20. PubMed ID: 16447239
    [Abstract] [Full Text] [Related]

  • 8. Down-regulation of CD40 and CD80 on B cells in patients with life-threatening systemic lupus erythematosus after successful treatment with rituximab.
    Tokunaga M, Fujii K, Saito K, Nakayamada S, Tsujimura S, Nawata M, Tanaka Y.
    Rheumatology (Oxford); 2005 Feb; 44(2):176-82. PubMed ID: 15494350
    [Abstract] [Full Text] [Related]

  • 9. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells.
    Sato S, Fujimoto M, Hasegawa M, Takehara K.
    Arthritis Rheum; 2004 Jun; 50(6):1918-27. PubMed ID: 15188368
    [Abstract] [Full Text] [Related]

  • 10. [Rituximab in systemic lupus erythematosus. Part I. Theoretical basis].
    Kardynał A, Rudnicka L.
    Pol Merkur Lekarski; 2010 Aug; 29(170):131-4. PubMed ID: 20842829
    [Abstract] [Full Text] [Related]

  • 11. A dose-escalation study of rituximab for treatment of systemic lupus erythematosus and Evans' syndrome: immunological analysis of B cells, T cells and cytokines.
    Tamimoto Y, Horiuchi T, Tsukamoto H, Otsuka J, Mitoma H, Kimoto Y, Nakashima H, Muta K, Abe Y, Kiyohara C, Ueda A, Nagasawa K, Yoshizawa S, Shimoda T, Harada M.
    Rheumatology (Oxford); 2008 Jun; 47(6):821-7. PubMed ID: 18397955
    [Abstract] [Full Text] [Related]

  • 12. Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab.
    Hoyer BF, Mumtaz IM, Loddenkemper K, Bruns A, Sengler C, Hermann KG, Maza S, Keitzer R, Burmester GR, Buttgereit F, Radbruch A, Hiepe F.
    Ann Rheum Dis; 2012 Jan; 71(1):75-9. PubMed ID: 21953334
    [Abstract] [Full Text] [Related]

  • 13. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.
    Leandro MJ, Cambridge G, Edwards JC, Ehrenstein MR, Isenberg DA.
    Rheumatology (Oxford); 2005 Dec; 44(12):1542-5. PubMed ID: 16188950
    [Abstract] [Full Text] [Related]

  • 14. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C, Börjesson-Asp K, Zendjanchi K, Sundqvist AC, Tarkowski A, Bokarewa M.
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [Abstract] [Full Text] [Related]

  • 15. Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial.
    Sfikakis PP, Boletis JN, Lionaki S, Vigklis V, Fragiadaki KG, Iniotaki A, Moutsopoulos HM.
    Arthritis Rheum; 2005 Feb; 52(2):501-13. PubMed ID: 15693003
    [Abstract] [Full Text] [Related]

  • 16. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus.
    Jacobi AM, Odendahl M, Reiter K, Bruns A, Burmester GR, Radbruch A, Valet G, Lipsky PE, Dörner T.
    Arthritis Rheum; 2003 May; 48(5):1332-42. PubMed ID: 12746906
    [Abstract] [Full Text] [Related]

  • 17. Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE.
    Vallerskog T, Gunnarsson I, Widhe M, Risselada A, Klareskog L, van Vollenhoven R, Malmström V, Trollmo C.
    Clin Immunol; 2007 Jan; 122(1):62-74. PubMed ID: 17046329
    [Abstract] [Full Text] [Related]

  • 18. Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment.
    Smith KG, Jones RB, Burns SM, Jayne DR.
    Arthritis Rheum; 2006 Sep; 54(9):2970-82. PubMed ID: 16947528
    [Abstract] [Full Text] [Related]

  • 19. An open study of B lymphocyte depletion in systemic lupus erythematosus.
    Leandro MJ, Edwards JC, Cambridge G, Ehrenstein MR, Isenberg DA.
    Arthritis Rheum; 2002 Oct; 46(10):2673-7. PubMed ID: 12384926
    [Abstract] [Full Text] [Related]

  • 20. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients.
    Lu TY, Ng KP, Cambridge G, Leandro MJ, Edwards JC, Ehrenstein M, Isenberg DA.
    Arthritis Rheum; 2009 Apr 15; 61(4):482-7. PubMed ID: 19333973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.